NexGenEsis Healthcare vs ACASA Senior Care

ACASA Senior Care is the stronger opportunity right now, and it’s not close. The decisive dimension is budget. ACASA’s $6.9M AUV signals a business with genuine operational complexity and the cash flow to invest in software that goes beyond bare-minimum compliance. A 40% unit growth rate on a small base means every new location is a greenfield deployment opportunity, and the approved-supplier procurement model means we don’t have to fight a corporate-mandated tech stack to get in the door. The tradeoff is a tiny total addressable market—eight units total, seven franchised—so we’d be betting on continued expansion to build a meaningful book of business.

NexGenEsis looks like a trap if we’re chasing software revenue. A $179K AUV is alarmingly low for a healthcare franchise; that’s a side-hustle, not an operating business with budget for a multi-module platform. The franchisor-controlled procurement model slams the door on direct sales to franchisees, forcing us through a corporate gatekeeper who likely views software as a cost center, not a value driver. Yes, they have more total units, but terrain and budget wipe out any TAM advantage—fourteen units with no money and a locked-down supply chain don’t add up to a pipeline.

The only scenario where NexGenEsis wins is if we have a pre-existing corporate relationship and can land a mandatory, royalty-funded deployment across the system. Absent that, ACASA’s high-revenue, high-growth, open-terrain profile makes it the clear pick for direct franchisee sales.

Verdict: ACASA Senior Care wins on budget and terrain, despite a painfully small current TAM.